Non-replicating Epstein-Barr Virus-based Plasmids Extend Gene Expression and Can Improve Gene Therapy in Vivo
Open Access
- 1 September 2000
- journal article
- Published by Elsevier
- Vol. 275 (39) , 30408-30416
- https://doi.org/10.1074/jbc.m004782200
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Selective extraction of polyoma DNA from infected mouse cell culturesPublished by Elsevier ,2004
- Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomesGene Therapy, 1998
- A second dose of a CFTR cDNA–liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice tracheaGene Therapy, 1997
- Prolonged Expression of Therapeutic Levels of Human Granulocyte Colony-Stimulating Factor in Rats Following Gene Transfer to Skeletal MuscleHuman Gene Therapy, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase geneJournal of General Virology, 1996
- Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporterVirus Research, 1993
- Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.The Journal of Experimental Medicine, 1992
- Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4− CD8+ cytotoxic T lymphocytes in miceEuropean Journal of Immunology, 1992
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985